FTCM
CBMG

First Trust Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

First Trust Capital Management’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,688
Closed -$601K – 292
2020
Q4 		$601K Sell
32,688
-2,925
-8% -$53.3K 0.17% 100
2020
Q3 		$653K Buy
+35,613
New +$599K 0.18% 70

First Trust Capital Management's CBMG Position: Q1 2021 in Review

First Trust Capital Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 32,688 shares — an estimated $601K sold.

First Trust Capital Management first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $653K in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • First Trust Capital Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • First Trust Capital Management sold 32,688 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $601K.
  • First Trust Capital Management first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • First Trust Capital Management's Cellular Biomedicine Group, Inc. position peaked at $653K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on First Trust Capital Management's 13F filing for Q1 2021, filed 17 May 2021.